| MR编号 | SI/H/0172/001 |
|---|
| 药品名称 | Meropenem AptaPharma 500 mg powder for solution for injection/infusion |
|---|
| 活性成分 | - Meropenem trihydrate 500.0 mg
|
|---|
| 剂型 | Powder for solution for injection/infusion |
|---|
| 上市许可持有人 | Apta Medica Internacional d.o.o.
Likozarjeva ulica 6
1000 Ljubljana
Slovenia |
|---|
| 参考成员国 - 产品名称 | Slovenia (SI) Meropenem AptaPharma 500 mg prašek za raztopino za injiciranje/infundiranje |
|---|
| 互认成员国 - 产品名称 | - Austria (AT)
Meropenem AptaPharma 500 mg Pulver zur Herstellung einer Injektions-/ Infusionslösung - Hungary (HU)
MEROPENEM APTAPHARMA 500 mg por oldatos injekcióhoz vagy infúzióhoz - Denmark (DK)
- Croatia (HR)
Meropenem AptaPharma 500 mg prašak za otopinu za injekciju/infuziju - Netherlands (NL)
- Cyprus (CY)
Meropenem ActaPharma 500mg powder for solution for infusion - Bulgaria (BG)
Meropenenm AptaPharma - Romania (RO)
Meropenem AptaPharma 500 mg pulbere pentru soluţie injectabilă/ - Malta (MT)
- Poland (PL)
Meropenem AptaPharma - Czechia (CZ)
Meropenem AptaPharma - Sweden (SE)
- Norway (NO)
- Finland (FI)
- Slovakia (SK)
|
|---|
| 许可日期 | 2017/12/01 |
|---|
| 最近更新日期 | 2025/01/28 |
|---|
| 药物ATC编码 | |
|---|
| 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|